ArticleCureus2026

Successful Use of Chimeric Antigen Receptor T-cell (CAR-T) Therapy With Lisocabtagene Maraleucel in a Renal Transplant Recipient With Refractory/Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).

Waqqas Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.